175 related articles for article (PubMed ID: 11367533)
1. Complement C3b interactions studied with surface plasmon resonance technique.
Jokiranta TS; Westin J; Nilsson UR; Nilsson B; Hellwage J; Löfås S; Gordon DL; Ekdahl KN; Meri S
Int Immunopharmacol; 2001 Mar; 1(3):495-506. PubMed ID: 11367533
[TBL] [Abstract][Full Text] [Related]
2. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.
Sahu A; Isaacs SN; Soulika AM; Lambris JD
J Immunol; 1998 Jun; 160(11):5596-604. PubMed ID: 9605165
[TBL] [Abstract][Full Text] [Related]
3. Each of the three binding sites on complement factor H interacts with a distinct site on C3b.
Jokiranta TS; Hellwage J; Koistinen V; Zipfel PF; Meri S
J Biol Chem; 2000 Sep; 275(36):27657-62. PubMed ID: 10837479
[TBL] [Abstract][Full Text] [Related]
4. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.
Ross GD; Newman SL; Lambris JD; Devery-Pocius JE; Cain JA; Lachmann PJ
J Exp Med; 1983 Aug; 158(2):334-52. PubMed ID: 6224880
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Binding Properties of Individual Functional Sites of Human Complement Factor H.
Haque A; Cortes C; Alam MN; Sreedhar M; Ferreira VP; Pangburn MK
Front Immunol; 2020; 11():1728. PubMed ID: 32849614
[TBL] [Abstract][Full Text] [Related]
6. A revised mechanism for the activation of complement C3 to C3b: a molecular explanation of a disease-associated polymorphism.
Rodriguez E; Nan R; Li K; Gor J; Perkins SJ
J Biol Chem; 2015 Jan; 290(4):2334-50. PubMed ID: 25488663
[TBL] [Abstract][Full Text] [Related]
7. Kinetic analysis of the interactions of complement receptor 2 (CR2, CD21) with its ligands C3d, iC3b, and the EBV glycoprotein gp350/220.
Sarrias MR; Franchini S; Canziani G; Argyropoulos E; Moore WT; Sahu A; Lambris JD
J Immunol; 2001 Aug; 167(3):1490-9. PubMed ID: 11466369
[TBL] [Abstract][Full Text] [Related]
8. Segment spanning residues 727-768 of the complement C3 sequence contains a neoantigenic site and accommodates the binding of CR1, factor H, and factor B.
Becherer JD; Alsenz J; Esparza I; Hack CE; Lambris JD
Biochemistry; 1992 Feb; 31(6):1787-94. PubMed ID: 1371073
[TBL] [Abstract][Full Text] [Related]
9. Combining SPR with atomic-force microscopy enables single-molecule insights into activation and suppression of the complement cascade.
Makou E; Bailey RG; Johnston H; Parkin JD; Hulme AN; Hähner G; Barlow PN
J Biol Chem; 2019 Dec; 294(52):20148-20163. PubMed ID: 31719147
[TBL] [Abstract][Full Text] [Related]
10. Complement C3b/C3d and cell surface polyanions are recognized by overlapping binding sites on the most carboxyl-terminal domain of complement factor H.
Hellwage J; Jokiranta TS; Friese MA; Wolk TU; Kampen E; Zipfel PF; Meri S
J Immunol; 2002 Dec; 169(12):6935-44. PubMed ID: 12471127
[TBL] [Abstract][Full Text] [Related]
11. Mapping the Complement Factor H-Related Protein 1 (CFHR1):C3b/C3d Interactions.
Hannan JP; Laskowski J; Thurman JM; Hageman GS; Holers VM
PLoS One; 2016; 11(11):e0166200. PubMed ID: 27814381
[TBL] [Abstract][Full Text] [Related]
12. Glomerular CR1 express in situ cofactor activity for degradation of C3b.
Vedeler CA; Matre R; Iversen BM
Int Arch Allergy Appl Immunol; 1990; 92(1):60-3. PubMed ID: 2147176
[TBL] [Abstract][Full Text] [Related]
13. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
Davis AE; Harrison RA; Lachmann PJ
J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952
[TBL] [Abstract][Full Text] [Related]
14. Common binding region of complement factors B, H and CR1 on C3b revealed by monoclonal anti-C3d.
Koistinen V; Wessberg S; Leikola J
Complement Inflamm; 1989; 6(4):270-80. PubMed ID: 2527715
[TBL] [Abstract][Full Text] [Related]
15. Cleavage of the complement system C3 component by HIV-1 proteinase.
Kisselev AF; Mentele R; von der Helm K
Biol Chem; 1997 May; 378(5):439-42. PubMed ID: 9191031
[TBL] [Abstract][Full Text] [Related]
16. A discontinuous factor H binding site in the third component of complement as delineated by synthetic peptides.
Lambris JD; Avila D; Becherer JD; Müller-Eberhard HJ
J Biol Chem; 1988 Aug; 263(24):12147-50. PubMed ID: 2969896
[TBL] [Abstract][Full Text] [Related]
17. Evidence for three binding sites for C3 (hemolytically inactive), C3b and C3d on a CR2-positive Burkitt lymphoma-derived cell line (Raji).
Barile G; Di Renzo L; Lipari M; Frati L; Faggioni A
FEBS Lett; 1993 Jun; 324(3):319-24. PubMed ID: 8405374
[TBL] [Abstract][Full Text] [Related]
18. The binding of human complement proteins C5, factor B, beta 1H and properdin to complement fragment C3b on zymosan.
DiScipio RG
Biochem J; 1981 Dec; 199(3):485-96. PubMed ID: 6462133
[TBL] [Abstract][Full Text] [Related]
19. Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement.
Kajander T; Lehtinen MJ; Hyvärinen S; Bhattacharjee A; Leung E; Isenman DE; Meri S; Goldman A; Jokiranta TS
Proc Natl Acad Sci U S A; 2011 Feb; 108(7):2897-902. PubMed ID: 21285368
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the human alternative complement pathway: formation of a ternary complex between factor H, surface-bound C3b and chemical groups on nonactivating surfaces.
Carreno MP; Labarre D; Maillet F; Jozefowicz M; Kazatchkine MD
Eur J Immunol; 1989 Nov; 19(11):2145-50. PubMed ID: 2480904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
